Safety and feasibility of injection with an E1 B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial. - Mulvihill,S.; Warren,R.; Venook,A. (Gene Ther, 2001)